These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30398036)

  • 41. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of serum adipose triglyceride lipase levels with obesity and diabetes.
    Yang L; Chen SJ; Yuan GY; Zhou LB; Wang D; Wang XZ; Chen JJ
    Genet Mol Res; 2014 Aug; 13(3):6746-51. PubMed ID: 25177954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased Serum Level of miR-155 is Associated with Obesity and its Related Metabolic Traits.
    Mahdavi R; Ghorbani S; Alipoor B; Panahi G; Khodabandehloo H; Esfahani EN; Razi F; Meshkani R
    Clin Lab; 2018 Jan; 64(1):77-84. PubMed ID: 29479888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai.
    Chanchay S; Tungtrongchitr R; Harnroongroj T; Phonrat B; Rungseesakorn O; Paksanont S; Pooudong S; Saowakontha S; Varongchayakul C
    Int J Vitam Nutr Res; 2006 May; 76(3):125-31. PubMed ID: 17048191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects.
    Ghorbani S; Mahdavi R; Alipoor B; Panahi G; Nasli Esfahani E; Razi F; Taghikhani M; Meshkani R
    Arch Physiol Biochem; 2018 Oct; 124(4):300-305. PubMed ID: 29113498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients.
    Furuta M; Tamai M; Hanabusa T; Yamamoto Y; Nanjo K; Sanke T
    Diabetes Res Clin Pract; 2006 Jun; 72(3):302-7. PubMed ID: 16442181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
    Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
    Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
    Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
    Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes.
    Kim SH; Lee SH; Ahn KY; Lee DH; Suh YJ; Cho SG; Choi YJ; Lee DH; Lee SY; Hong SB; Kim YS; Jeon JY; Nam M
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):825-33. PubMed ID: 23682797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High serum fasting peptide YY (3-36) is associated with obesity-associated insulin resistance and type 2 diabetes.
    Ukkola OH; Puurunen VP; Piira OP; Niva JT; Lepojärvi ES; Tulppo MP; Huikuri HV
    Regul Pept; 2011 Oct; 170(1-3):38-42. PubMed ID: 21635925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum hemorphin-7 levels are decreased in obesity.
    Maraninchi M; Feron D; Fruitier-Arnaudin I; Bégu-Le Corroller A; Nogueira JP; Mancini J; Valéro R; Piot JM; Vialettes B
    Obesity (Silver Spring); 2013 Feb; 21(2):378-81. PubMed ID: 23532992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Reduced resistin levels in patients with type 2 diabetes mellitus].
    Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes.
    Ortega FJ; Sabater M; Moreno-Navarrete JM; Pueyo N; Botas P; Delgado E; Ricart W; Frühbeck G; Fernández-Real JM
    Eur J Endocrinol; 2012 Oct; 167(4):569-78. PubMed ID: 22822112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.